Screener
West Pharmaceutical Services WST Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Equity in net income of affiliated companies | (6.1) | (5.0) | (9.5) | (8.4) |
| Net income | $154.0 | $131.8 | $292.8 | $221.6 |
| Net income per share: | ||||
| Basic | $2.17 | $1.82 | $4.10 | $3.06 |
| Diluted | $2.15 | $1.82 | $4.07 | $3.05 |
| Weighted average shares outstanding: | ||||
| Basic | 70.8 | 72.2 | 71.4 | 72.3 |
| Diluted | 71.3 | 72.5 | 71.9 | 72.8 |
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is West Pharmaceutical Services's shares (diluted)?
- West Pharmaceutical Services (WST) reported shares (diluted) of 71.3M in Q2 2026.
- How has West Pharmaceutical Services's shares (diluted) changed year-over-year?
- West Pharmaceutical Services's shares (diluted) decreased by 1.7% year-over-year, from 72.5M to 71.3M.
- What is the long-term trend for West Pharmaceutical Services's shares (diluted)?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's shares (diluted) has grown at a -1.1% compound annual growth rate (CAGR), from 303.8M to 290.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about West Pharmaceutical Services's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude